Triumph Capital Management’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.2K Buy
2,144
+273
+15% +$4.98K 0.01% 734
2026
Q1
$31.4K Sell
1,871
-1,430
-43% -$26.9K 0.01% 753
2025
Q4
$63.1K Sell
3,301
-24,689
-88% -$453K 0.01% 556
2025
Q3
$484K Buy
27,990
+5,097
+22% +$86.8K 0.13% 165
2025
Q2
$421K Buy
22,893
+2,704
+13% +$50.2K 0.13% 184
2025
Q1
$417K Buy
20,189
+1,187
+6% +$24.3K 0.14% 176
2024
Q4
$359K Buy
19,002
+1,234
+7% +$25.5K 0.12% 192
2024
Q3
$392K Buy
+17,768
New +$380K 0.14% 163

Other funds holding THQ

Triumph Capital Management's THQ Position: Q2 2026 in Review

Triumph Capital Management increased its abrdn Healthcare Opportunities Fund (THQ) stake by 15% in Q2 2026, buying an estimated $4.98K and bringing the position to 2,144 shares worth $40.2K. The position accounts for 0.01% of the portfolio, ranked #734.

Triumph Capital Management first reported a position in THQ in Q3 2024 and has held it in 8 quarters since. The position peaked at $484K in Q3 2025. 97 funds tracked by Wall St. Rank hold THQ as of Q2 2026.

  • Triumph Capital Management held 2,144 shares of abrdn Healthcare Opportunities Fund worth $40.2K as of Q2 2026.
  • Triumph Capital Management bought 273 abrdn Healthcare Opportunities Fund shares in Q2 2026, an estimated $4.98K.
  • abrdn Healthcare Opportunities Fund made up 0.01% of Triumph Capital Management's portfolio in Q2 2026, its #734 holding.
  • Triumph Capital Management first reported a position in abrdn Healthcare Opportunities Fund in Q3 2024 and has held it in 8 quarters since.
  • Triumph Capital Management's abrdn Healthcare Opportunities Fund position peaked at $484K in Q3 2025.
  • 97 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.